Search / Trial NCT06616792

Dexamethasone Phonophoresis Versus Laser Acupuncture on Chronic Rhinosinusitis

Launched by CAIRO UNIVERSITY · Sep 25, 2024

Trial Information

Current as of December 30, 2024

Enrolling by invitation

Keywords

Dexamethasone Phonophoresis, Laser Acupuncture, Chronic Rhinosinusitis

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age range between 30 to 50 years.
  • Male and female patients will participate in the study.
  • * All patients have chronic rhinosinusitis, who are experiencing 12 weeks or longer of 2 or more of the following signs and symptoms:
  • mucopurulent drainage (anterior, posterior, or both) nasal obstruction (congestion) facial pain-pressure-fullness, or decreased sense of smell
  • • All patients enrolled in the study will have their informed consent.
  • Exclusion Criteria:
  • Patients with metal implants (pacemakers, dental implants, or any other implants).
  • Patients with cancer, pregnancy or impaired vascular circulation.
  • Patients who suffer from mental or psychological disorders.
  • Patients with any systemic diseases that may interfere with the objectives of the study.
  • Patients with long-term use of corticosteroids or immunosuppressive agents.
  • Congenital defects on face and nose.
  • Fracture of nose or face.
  • Patients who are contraindicated for corticosteroids use in patient who will receive dexamethasone phonophoresis.
  • Allergic patients.
  • Pervious nasal surgery.
  • Patients with nasal septum deviation.
  • patients who had used antihistamines within 1 week, topical corticosteroids within2 weeks, systemic corticosteroids within 4 weeks, anti-cholinergic drugs within 3 days, antileukotriene drugs within 1 week, decongestants within 3 days, tricyclic antidepressants or phenothiazines within 2 weeks, non-steroidal analgesics within 2 weeks or any medication that may interfere with the objectives of the study.

Trial Officials

Walaa Abd Elaziem Abd Elaziz Walaa Abd Elaziem Abd Elaziz, Doctoral degree

Principal Investigator

Cairo University

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Dokki, Giza, Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0